TransCon hGH

Go or no go? Aducanumab’s day of reckoning
EP Vantage
Thu, 05/27/21 - 10:56 am
Biogen
FDA
aducanumab
Ascendis Pharma
Novo Nordisk
TransCon hGH
semaglutide
Ascendis jumps on Phase III readout for once-weekly growth hormone
BioCentury
Mon, 03/4/19 - 05:14 pm
Ascendis
TransCon hGH
pediatric growth hormone deficiency
clinical trials
Upcoming events – Ascendis and Lilly hope for growth with pivotal data
EP Vantage
Fri, 02/1/19 - 11:58 am
Ascendis
clinical trials
pediatric growth hormone deficiency
TransCon hGH
Eli Lilly
olumiant
eczema